Home > Journals > Minerva Chirurgica > Past Issues > Articles online first > Minerva Chirurgica 2020 May 26

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

Minerva Chirurgica 2020 May 26

DOI: 10.23736/S0026-4733.20.08299-1

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Obstructive left side colon cancer: time for a tailored operative approach?

Carlo BERGAMINI 1 , Alessio GIORDANO 1, Gherardo MALTINTI 1, Giovanni ALEMANNO 1, Fabio CIANCHI 2, Andrea CORATTI 3, Roberto MANETTI 4, Andrea VALERI 1, Paolo PROSPERI 1

1 Emergency Surgery Unit, Department of Emergency, University Hospital of Careggi, Florence, Italy; 2 General and Endocrine Surgery Unit, Department of Emergency, University Hospital of Careggi, Florence, Italy; 3 Department of Robotic Oncologic Surgery, University Hospital of Careggi, Florence, Italy; 4 Operative Endoscopy Unit, Department of Robotic Oncologic Surgery, University Hospital of Careggi, Florence, Italy


PDF


BACKGROUND: Colorectal cancer (CRC) obstruction is frequent but doubts remain on the best treatment. The aim of this study is to analyze the different operative approach used for CRC treatment and evaluate the outcomes for the different cases.
MATERIALS AND METHODS: Patients were collected from January 2014 to December 2019 and divided in four groups (PH = Hartmann's procedure, PA = primary anastomosis - P groups - SD = deviating stoma, SS = SEMS - S groups). The main end-points were the quality of life and the oncologic safety.
RESULTS: 108 patients were enrolled. The mean follow-up time was 39 months. The stomas were performed less frequently in SS but lasted more in that group. Only 45% underwent reversal surgery. Cumulative operating time was greater in S vs P. The rate of major complications was similar. PA had a greater overall survival and disease-free survival than PH.
CONCLUSIONS: The various options of treatment should have different indications: primary anastomosis in stable patients, Hartmann in critical cases, SEMS for palliative intent and stoma when neo-adjuvant therapy is needed.


KEY WORDS: Colon cancer; Stent positioning; Tailored therapy

top of page